510(k) device
MiniMed Flex pump
Medtronic Minimed, Inc. · Alternate Controller Enabled Insulin Infusion Pump (QFG, Class II) · First FDA decision Mar 12, 2026, newest Mar 12, 2026Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "MiniMed Flex"
MAUDE reports
0
Brand "MiniMed Flex", since 2015
PubMed studies
0
Mentioning "MiniMed Flex"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MiniMed Flex pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Insulin Infusion PumpNational analysisReview closedCAG-00041NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "MiniMed Flex", any status and sponsor, newest update first.
- Relieving Carb Counting Via Flexible-userinteraction Multiple-input Control ArchitecturesNot yet recruiting
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalAcademic, hospital or other
NCT07031492 · 10 participants (planned) · Start Sep 2025 · Primary completion Dec 2025
Device: FLEX-AP system will be implemented to T1D patients · For: T1DM - Type 1 Diabetes Mellitus
Sites: Madrid, Spain
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MiniMed Flex", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFG
1,370,384 reports: 1,216,047 malfunction, 153,806 injury, 383 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0088-2027 · Started Aug 20, 2026 · Posted by FDA Oct 5, 2026
Reason given: Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues:...
Cause as FDA categorized it: Under Investigation by firm · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Published research
The most relevant PubMed records for "MiniMed Flex"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QFG.
- Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 510(k) 2025
- t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc. · De Novo 2025
- iLet ACE PumpBeta Bionics, Inc. · 510(k) 2026
- DEKA ACE Pump SystemDeka Research and Development · 510(k) 2024
- Mint ACE PumpBeta Bionics, Inc. · 510(k) 2026
- MiniMed 780G Insulin Pump (MMT-1884)Medtronic Minimed, Inc. · 510(k) 2026
- Omnipod 5 ACE PumpInsulet Corporation · 510(k) 2023
- twiist Automated Insulin Delivery (AID) SystemDeka Research and Development · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.